Ads
related to: crispr stock- Biotech Insights
Biotech bolsters the market but
tailwinds for services and HCIT.
- About Us
RBC's History, Culture & Values
Learn More
- Biotech Balancing Act
Biotech juggles innovation,
competition, policy, and funding.
- Expertise
Our Expertise Ranges Across a Large
Set of Industries and Markets
- Raising Capital
A new playbook for a new era
in biotech.
- ECM: Robust End To Year
The rise of creative deal
structures in biotech.
- Biotech Insights
Search results
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 1.8%
ETF DAILY NEWS· 2 days agoShares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) dropped 1.8% on Monday . The stock traded as low as $61.36 and last ...
CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks via Yahoo Finance· 12 hours agoCRISPR Therapeutics AG (CRSP) closed at $59.60 in the latest trading session, marking a -1.6% move...
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 2 days agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Acquired by Greenwood Capital Associates LLC
ETF DAILY NEWS· 4 days agoGreenwood Capital Associates LLC boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 23.8% during the fourth quarter, according ...
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks via Yahoo Finance· 4 days agoEditas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies...
Intellia (NTLA) Banks on Genome Editing Pipeline Amid Rivalry
Zacks via Yahoo Finance· 7 days agoIntellia's (NTLA) lead genome-editing candidate, NTLA-2001 being developed to treat transthyretin...
Behind the Scenes of Intellia Therapeutics's Latest Options Trends - Intellia Therapeutics...
Benzinga· 14 hours agoCrispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is ...
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Motley Fool via Yahoo Finance· 6 days agoGrowth at a more-than-reasonable price Keith Speights (Vertex Pharmaceuticals): If the thought of...
Gene Therapy Improves Vision in Rare, Inherited Eye Disorder
Medscape· 2 days agoEDIT-101, a CRISPR-based gene editing therapy, shows promise in patients with retinal degeneration...
Gene editing technology is revolutionizing disease treatment | The Excerpt
USA Today· 13 hours agoOn a special episode (first released on June 20, 2024) of The Excerpt podcast: With the advent of ...
Ads
related to: crispr stock